Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2025 Jul;13(7):e1258-e1267.
doi: 10.1016/S2214-109X(25)00150-0.

Colorimetric RT-LAMP for SARS-CoV-2 detection from nasopharyngeal swabs or crude saliva: a multicountry diagnostic accuracy study in Africa

Collaborators, Affiliations
Multicenter Study

Colorimetric RT-LAMP for SARS-CoV-2 detection from nasopharyngeal swabs or crude saliva: a multicountry diagnostic accuracy study in Africa

Urša Šušnjar et al. Lancet Glob Health. 2025 Jul.

Abstract

Background: Reverse-transcription loop-mediated isothermal amplification (RT-LAMP) with colorimetric readout is a rapid, robust, and cost-effective one-step amplification assay that we previously trialled for the identification of SARS-CoV-2 in nasopharyngeal swabs in four countries. Here, we expanded our assessment of RT-LAMP for SARS-CoV-2 detection to several other African countries and evaluated its operational performance with crude saliva as a pragmatic approach for outbreak surveillance and response in resource-limited settings.

Methods: We conducted a multicountry diagnostic accuracy study of RT-LAMP for the detection of SARS-CoV-2 in different types of clinical samples. A preliminary study was conducted in Slovenia and Italy to establish the analytical performance (limit of detection) of RT-LAMP and optimise this assay before its deployment in Africa. Subsequently, we tested RT-LAMP with RNA extracted from nasopharyngeal swabs in seven countries in Africa (Angola, Burkina Faso, Côte d'Ivoire, Ethiopia, Senegal, Sudan, and Zimbabwe), and, in parallel, with crude saliva samples (ie, without RNA extraction) in an additional four countries (Cameroon, Ethiopia, Kenya, and Nigeria; paired nasopharyngeal swabs were collected at the same time). In both contexts, quantitative RT-PCR (RT-qPCR) with RNA extracted from nasopharyngeal swabs was used as the gold-standard benchmarking assay to evaluate performance. For RT-qPCR testing, each laboratory followed their own standard diagnostic procedure, whereas a standardised protocol was used for RT-LAMP. Saliva test standardisation was ensured through centralised reagent distribution. We calculated diagnostic parameters (sensitivity, specificity, and accuracy) using a 2 × 2 contingency table.

Findings: The preliminary study reported 87% sensitivity and 98% specificity for RT-LAMP. Between Sept 1, 2021, and June 30, 2022, we collected 2774 nasopharyngeal swabs and 577 crude saliva samples. For RNA extracted from nasopharyngeal swabs, the sensitivity and specificity of RT-LAMP for detection of SARS-CoV-2 (relative to the standard of diagnostics-ie, the RT-qPCR assay used in each participating laboratory) were 89% (95% CI 87-90) and 95% (93-96), respectively. Similarly, RT-LAMP tested on saliva without RNA extraction showed 80% (75-84) sensitivity and 99% (96-100) specificity (relative to the results obtained with the standard of diagnostics for RNA extracted from paired nasopharyngeal samples).

Interpretation: Colorimetric RT-LAMP is a reliable assay for SARS-CoV-2 detection in both extracted RNA and crude saliva samples. The demonstrably acceptable performance on crude saliva samples (without RNA extraction) underscores the scalability of this method for efficient outbreak surveillance in resource-limited settings.

Funding: Gates Foundation.

PubMed Disclaimer

Conflict of interest statement

Declaration of interests We declare no competing interests.

Figures

Figure 1
Figure 1
Study overview (A) Study scheme (left) and locations of participating countries conducting the two clinical trials (right). (B) Procedure for the clinical study on nasopharyngeal swabs; figure created with Biorender.com. (C) Procedure for the clinical study on saliva; figure created with Biorender.com. RT-LAMP=reverse transcription loop-mediated isothermal amplification. RT-qPCR=quantitative RT-PCR.
Figure 2
Figure 2
Viral loads in paired nasopharyngeal swab and saliva samples (A) Scatter plot shows low correlation between Ct values for paired nasopharyngeal swab and saliva samples from individuals diagnosed positive for SARS-CoV-2 as assessed by RT-qPCR (n=186). (B) Ct values from the plot in panel A were normalised for an internal control (UBC) in each sample (n=177; nine samples were excluded as no signal was obtained for UBC). (C) Box plot of Ct values from panel A. Boxes indicate limits of the first and third quartile; lines show the median; whiskers represent 1·5-times the IQR. (D) Ct values from panel C were normalised for an internal control (UBC) in each sample (n=177). Boxes indicate limits of the first and third quartile; lines show the median; whiskers represent 1·5-times the IQR. (E) Correlation of viral loads in positive saliva samples as assessed by RT-qPCR using two different assays in two laboratories at distinct timepoints (n=188; five samples were excluded from quantification as saliva volume was insufficient for additional analysis). Dashed lines in A, B, and E represent y=x. Ct=cycle threshold.RT-LAMP=reverse transcription loop-associated isothermal amplification.
Figure 3
Figure 3
Sensitivity of RT-LAMP for detection of SARS-CoV-2 in crude saliva samples (A) Sensitivity of RT-LAMP with crude saliva samples and RT-qPCR (LightMix) with RNA purified from saliva samples relative to the reference diagnostic method, stratified by RT-qPCR Ct values; n=144 for Ct <25; n=53 for Ct ≥25 (three positive samples [as assessed by RT-qPCR] were excluded due to an inconclusive colour change in RT-LAMP). (B) Sensitivity of RT-LAMP with crude saliva samples relative to RT-qPCR (LightMix) on RNA extracted from saliva, stratified by RT-qPCR Ct values. (C) Sensitivity of RT-LAMP as in panel A stratified by the number of genome copies per μL of saliva (upper plot) quantified with RT-qPCR (Luna); number of samples in each concentration range (count; lower plot). (D) Limit of detection of RT-LAMP for crude saliva samples lysed in saliva lysis buffer (n=193 SARS-CoV-2-positive individuals, as diagnosed by RT-qPCR on RNA extracted from saliva). Sensitivity values (thick lines) in A–C are shown with 95% CIs (whiskers). RT-LAMP=reverse transcription loop-mediated isothermal amplification. Ct=cycle threshold. RT-qPCR=quantitative RT-PCR.
Figure 4
Figure 4
Sensitivity and specificity of colorimetric RT-LAMP with RNA extracted from nasopharyngeal swabs RT-LAMP was conducted with RNA extracted from nasopharyngeal swabs (A) or with crude saliva samples (B). Sensitivity and specificity were calculated relative to the standard of diagnosis. Dashed lines represent the overall specificity or sensitivity of RT-LAMP relative to the standard of diagnosis. Error bars indicate 95% CIs. RT-LAMP=reverse transcription loop-mediated isothermal amplification.

Similar articles

  • PD-LAMP smartphone detection of SARS-CoV-2 on chip.
    Colbert AJ, Lee DH, Clayton KN, Wereley ST, Linnes JC, Kinzer-Ursem TL. Colbert AJ, et al. Anal Chim Acta. 2022 Apr 22;1203:339702. doi: 10.1016/j.aca.2022.339702. Epub 2022 Mar 9. Anal Chim Acta. 2022. PMID: 35361434 Free PMC article.
  • Rapid, point-of-care antigen tests for diagnosis of SARS-CoV-2 infection.
    Dinnes J, Sharma P, Berhane S, van Wyk SS, Nyaaba N, Domen J, Taylor M, Cunningham J, Davenport C, Dittrich S, Emperador D, Hooft L, Leeflang MM, McInnes MD, Spijker R, Verbakel JY, Takwoingi Y, Taylor-Phillips S, Van den Bruel A, Deeks JJ; Cochrane COVID-19 Diagnostic Test Accuracy Group. Dinnes J, et al. Cochrane Database Syst Rev. 2022 Jul 22;7(7):CD013705. doi: 10.1002/14651858.CD013705.pub3. Cochrane Database Syst Rev. 2022. PMID: 35866452 Free PMC article.
  • An alternative real-time fluorescence reverse transcription loop-mediated isothermal amplification assay for the rapid detection of SARS-CoV-2.
    Rudeeaneksin J, Klayut W, Phetsuksiri B, Uppapong B, Wongchai T, Chuenchom N. Rudeeaneksin J, et al. Rev Inst Med Trop Sao Paulo. 2025 Jun 27;67:e37. doi: 10.1590/S1678-9946202567037. eCollection 2025. Rev Inst Med Trop Sao Paulo. 2025. PMID: 40608622 Free PMC article.
  • Antibody tests for identification of current and past infection with SARS-CoV-2.
    Fox T, Geppert J, Dinnes J, Scandrett K, Bigio J, Sulis G, Hettiarachchi D, Mathangasinghe Y, Weeratunga P, Wickramasinghe D, Bergman H, Buckley BS, Probyn K, Sguassero Y, Davenport C, Cunningham J, Dittrich S, Emperador D, Hooft L, Leeflang MM, McInnes MD, Spijker R, Struyf T, Van den Bruel A, Verbakel JY, Takwoingi Y, Taylor-Phillips S, Deeks JJ; Cochrane COVID-19 Diagnostic Test Accuracy Group. Fox T, et al. Cochrane Database Syst Rev. 2022 Nov 17;11(11):CD013652. doi: 10.1002/14651858.CD013652.pub2. Cochrane Database Syst Rev. 2022. PMID: 36394900 Free PMC article.
  • Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.
    Struyf T, Deeks JJ, Dinnes J, Takwoingi Y, Davenport C, Leeflang MM, Spijker R, Hooft L, Emperador D, Domen J, Tans A, Janssens S, Wickramasinghe D, Lannoy V, Horn SRA, Van den Bruel A; Cochrane COVID-19 Diagnostic Test Accuracy Group. Struyf T, et al. Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3. Cochrane Database Syst Rev. 2022. PMID: 35593186 Free PMC article.

References

    1. WHO Coronavirus disease (COVID-19 pandemic) https://www.who.int/emergencies/diseases/novel-coronavirus-2019
    1. Ranney ML, Griffeth V, Jha AK. Critical supply shortages—the need for ventilators and personal protective equipment during the Covid-19 pandemic. N Engl J Med. 2020;382:e41. - PubMed
    1. Sisay A, Abera A, Dufera B, et al. Diagnostic accuracy of three commercially available one step RT-PCR assays for the detection of SARS-CoV-2 in resource limited settings. PLoS One. 2022;17 - PMC - PubMed
    1. Saxena A, Rai P, Mehrotra S, et al. Development and clinical validation of RT-LAMP-based lateral-flow devices and electrochemical sensor for detecting multigene targets in SARS-CoV-2. Int J Mol Sci. 2022;23 - PMC - PubMed
    1. Sahoo A, Shulania A, Chhabra M, et al. Performance of chip based real time RT-PCR (TrueNat) and conventional real time RT-PCR for detection of SARS-CoV-2. J Clin of Diagn Res. 2021;15:DC25–DC28.

Publication types

MeSH terms

Supplementary concepts